Medicare limits coverage Aduhelm, the $28,000-a-year Alzheimer’s drug from Biogen

Aduhelm’s initial yearly price of $56,000 led to the largest-ever increase, in dollars, for Medicare’s monthly „Part B” premium for outpatient care.